6
Oct
2026

HUADONG MEDICINE

Exhibitor at CPHI Milan 2026 stand 5A129, Integrated Pharma
About Us

Huadong medicine was established in 1993, headquartered in Hangzhou, China, is China's top 10 listed pharmaceutical and medical companies. The Company has more than 12,000 employees. In 2021, the Company's revenue stood at about 5.3billion USD. Huadong medicine are manufactuers of finished medicine, APIs and aesthetic medicine.We can provide immunosuppressant, antidiabetic, anti-infection, anti-tumor APIs and ADC toxins, Protected & modified nucleoside/nucleotide for Oligonucleotide and mRNA drugs. Our main products include: Mupirocin,Tacrolimus.......

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5A129, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Echinocandin B nucleus

    Product Echinocandin B nucleus

    1. Key intermediate for Anidulafungin

  • Gramicidin S

    Product Gramicidin S

    Gramicidin S is a homodetic cyclic peptide. A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidin S, A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN

  • Gramicidin

    Product Gramicidin

     Gramicidin is a heterogeneous mixture of six antibiotic peptides obtained from the soil bacterium Bacillus brevis. Gramicidin is active against most Gram-positive bacteria and against select Gram-negative organisms. It is administered as a topical application.

  • 2’-F Phosphoramidite
  • GalNAc-L96-Phosphoramidite